No reviews yet. Be the first to rate Daniel!
Dr Daniel Leongamornlert is a Staff Scientist in the Nangalia Group at the Wellcome Sanger Institute. He works on and supports projects studying myeloproliferative neoplasms and chronic myeloid leukaemia. His research interests include clonal trajectories and epigenetics, with a focus on the role of structural variants and mutational signatures in cancer.
Explore the groundbreaking Cancer Discovery study from Wellcome Sanger Institute tracking blood cancer evolution over 25 years, identifying genetic predictors for progression in UK patients.